Salt report published on the newspaper website Guardian The British highlighted an unfamiliar way to treat diseases by “transplanting human feces”.
The process of fecal transplantation takes place by placing the stool of a healthy person in the colon of a sick person, also called Fecal Microbiota Transplantation (FMT).
The report says that it is an effective treatment for a range of diseases, from irritable bowel syndrome to arthritis and even Alzheimer’s disease, and in this process a fecal cocktail is transferred by tube during a regular colonoscopy, or it can even be obtained in capsule form.
The newspaper report refers to the case of the Briton, Raymond, who suffered from many chronic diseases as a result of infection with Clostridium difficile (C diff), a bacterium that infects the colon, and its symptoms range from diarrhea to life-threatening colon damage.
The Briton underwent an antibiotic called “vancomycin”, which is an antibiotic that many patients respond to, but about a quarter of them experience a relapse, and among those 45 percent are exposed to a second relapse, which is what happened to Raymond, and these are the patients who usually benefit from the cultivation of fecal bacteria.
Although he initially refused to undergo the operation, he was forced to do so in the end as his condition deteriorated.
To perform the operation, donors must be obtained, and the samples may be fresh in the event that there are donors from friends and family members, and they can be obtained frozen. Potential stool donors undergo a rigorous questionnaire and medical interview, followed by a blood and stool examination.
Fresh samples should be taken within a short time of delivery, then diluted with sterile saline, filtered, and poured into a sterile bottle.
A fecal cocktail is drawn up during a colonoscopy.
The newspaper notes that the idea of fecal transplantation is old and has been used in the form of eating “yellow soup” since the fourth century AD to treat diarrhea.
In 1958, surgeon Ben Eiseman used fecal enemas on his patients in the US state of Colorado to treat severe and recurrent infections of Clostridium difficile (C diff).
Currently, the technology is being trialled worldwide for inflammatory bowel diseases, irritable bowel syndrome, obesity, severe malnutrition, diabetes, arthritis, hepatic encephalopathy (deterioration of brain function with severe liver disease), liver transplantation, and skin cancer. , autoimmune diseases, Alzheimer’s disease, bipolar disorder, hair loss, depression, neurodegenerative diseases, recurrent urinary tract infections and other diseases.
2023-06-12 13:05:54
#colon #obesity #depression. #faeces #promising #treatment #diseases
